Luminescent Gold Nanorods To Enhance the Near‐Infrared Emission of a Photosensitizer for Targeted Cancer Imaging and Dual Therapy: Experimental and Theoretical Approach. Issue 13 (28th January 2020)

• Record Type: Journal Article
• Authors: Nair, Resmi V.; Nair, Lakshmi V.; Govindachar, Divya Maldepalli; Santhakumar, Hema; Nazeer, Shaiju S.; Rekha, Charuvil Radhakrishnapillai; Shenoy, Sachin J.; Periyasamy, Ganga; Jayasree, Ramapurath S.
• Is Part Of: Chemistry. Volume 26:Issue 13(2020)
• Page Start: 2826
• Page End: 2836
• Publication Date: 2020-01-28
• Subjects: gold nanorods -- imaging agents -- protoporphyrin IX -- photodynamic therapy -- photothermal therapy; Chemistry -- Periodicals; 540
• DOI: 10.1002/chem.201904952
• Languages: English
• ISSNs: 0947-6539

Abstract

Abstract: Strong plasmon absorption in the near‐infrared (NIR) region renders gold nanorods (GNRs) amenable for biomedical applications, particularly for photothermal therapy. However, these nanostructures have not been explored for their imaging potential because of their weak emission profile. In this study, the weak fluorescence emission of GNRs is tuned to match that of the absorption of a photosensitizer (PS) molecule, and energy transfer from the GNR to PS enhances the emission profile of the GNR–PS combination. GNR complexes generally quench the fluorescence emission of nearby chromophores. However, herein, the complex retains or rather enhances the fluorescence through competition in energy transfer. Excitation‐dependent energy transfer has been explained experimentally and theoretically by using DFT calculations, the CIE chromaticity diagram, and power spectrum. The final GNR–PS complex modified for tumor specificity serves as an excellent organ‐specific theranostic probe for bioimaging and dual therapy both in vitro and in vivo. Principal component analysis designates photodynamic therapy a better candidate than that of photothermal therapy for long‐term efficacy in vivo. Abstract : Laser‐point accuracy : Near‐IR emission of protoporphyrin IX is enriched by the weak emission of plasmonic gold nanoparticles through a competitive charge‐transfer mechanism. The near‐IR emitting multifunctional system also has cancer‐targeting ability for imaging and multimodal therapy both in vitro and in vivo.